Goldman Sachs’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$214M Buy
2,729,848
+175,779
+7% +$13.7M 0.03% 470
2025
Q1
$185M Buy
2,554,069
+361,111
+16% +$26.2M 0.03% 474
2024
Q4
$162M Sell
2,192,958
-1,021,219
-32% -$75.6M 0.03% 488
2024
Q3
$212M Sell
3,214,177
-790,194
-20% -$52.1M 0.03% 425
2024
Q2
$370M Buy
4,004,371
+504,177
+14% +$46.6M 0.06% 268
2024
Q1
$334M Sell
3,500,194
-12,951
-0.4% -$1.24M 0.06% 290
2023
Q4
$268M Buy
3,513,145
+52,282
+2% +$3.99M 0.05% 342
2023
Q3
$240M Sell
3,460,863
-1,257,981
-27% -$87.2M 0.05% 313
2023
Q2
$445M Sell
4,718,844
-16,818
-0.4% -$1.59M 0.1% 162
2023
Q1
$392M Buy
4,735,662
+1,308,749
+38% +$108M 0.09% 181
2022
Q4
$256M Buy
3,426,913
+166,698
+5% +$12.4M 0.06% 289
2022
Q3
$269M Buy
3,260,215
+249,875
+8% +$20.6M 0.07% 253
2022
Q2
$286M Buy
3,010,340
+506,630
+20% +$48.2M 0.07% 241
2022
Q1
$295M Sell
2,503,710
-305,591
-11% -$36M 0.06% 268
2021
Q4
$364M Buy
2,809,301
+38,704
+1% +$5.01M 0.07% 231
2021
Q3
$314M Buy
2,770,597
+397,721
+17% +$45M 0.07% 244
2021
Q2
$246M Sell
2,372,876
-384,211
-14% -$39.8M 0.06% 292
2021
Q1
$231M Sell
2,757,087
-247,748
-8% -$20.7M 0.06% 288
2020
Q4
$274M Sell
3,004,835
-1,770,053
-37% -$161M 0.07% 221
2020
Q3
$381M Sell
4,774,888
-800,989
-14% -$63.9M 0.11% 138
2020
Q2
$385M Sell
5,575,877
-157,579
-3% -$10.9M 0.12% 142
2020
Q1
$360M Buy
5,733,456
+323,949
+6% +$20.4M 0.13% 131
2019
Q4
$421M Buy
5,409,507
+1,835,040
+51% +$143M 0.11% 166
2019
Q3
$262M Sell
3,574,467
-785,721
-18% -$57.6M 0.08% 259
2019
Q2
$269M Buy
4,360,188
+358,740
+9% +$22.1M 0.08% 241
2019
Q1
$255M Buy
4,001,448
+397,296
+11% +$25.3M 0.08% 239
2018
Q4
$184M Sell
3,604,152
-1,187,865
-25% -$60.6M 0.06% 310
2018
Q3
$278M Sell
4,792,017
-744,294
-13% -$43.2M 0.07% 264
2018
Q2
$269M Sell
5,536,311
-1,904,586
-26% -$92.4M 0.07% 253
2018
Q1
$346M Buy
7,440,897
+409,626
+6% +$19.1M 0.09% 224
2017
Q4
$264M Buy
7,031,271
+593,730
+9% +$22.3M 0.06% 301
2017
Q3
$235M Sell
6,437,541
-1,517,553
-19% -$55.3M 0.06% 305
2017
Q2
$314M Buy
7,955,094
+95,592
+1% +$3.77M 0.08% 202
2017
Q1
$246M Buy
7,859,502
+945,735
+14% +$29.7M 0.07% 257
2016
Q4
$216M Buy
6,913,767
+634,110
+10% +$19.8M 0.06% 299
2016
Q3
$252M Buy
6,279,657
+2,642,772
+73% +$106M 0.08% 213
2016
Q2
$121M Sell
3,636,885
-1,320,789
-27% -$43.9M 0.04% 465
2016
Q1
$146M Sell
4,957,674
-999,741
-17% -$29.4M 0.05% 404
2015
Q4
$157M Buy
5,957,415
+2,059,077
+53% +$54.2M 0.05% 364
2015
Q3
$92.4M Sell
3,898,338
-575,364
-13% -$13.6M 0.03% 512
2015
Q2
$106M Buy
4,473,702
+937,902
+27% +$22.3M 0.03% 499
2015
Q1
$84M Buy
3,535,800
+1,402,068
+66% +$33.3M 0.03% 581
2014
Q4
$45.3M Buy
2,133,732
+787,998
+59% +$16.7M 0.01% 874
2014
Q3
$22.9M Sell
1,345,734
-89,106
-6% -$1.52M 0.01% 1200
2014
Q2
$20.5M Sell
1,434,840
-149,550
-9% -$2.14M 0.01% 1250
2014
Q1
$19.6M Sell
1,584,390
-286,434
-15% -$3.54M 0.01% 1244
2013
Q4
$20.5M Sell
1,870,824
-8,978,628
-83% -$98.4M 0.01% 1204
2013
Q3
$126M Buy
10,849,452
+7,001,370
+182% +$81.3M 0.05% 357
2013
Q2
$43.1M Buy
+3,848,082
New +$43.1M 0.02% 708